BRPI0810710A2 - Método para estabilização de uma proteína. - Google Patents

Método para estabilização de uma proteína.

Info

Publication number
BRPI0810710A2
BRPI0810710A2 BRPI0810710-6A2A BRPI0810710A BRPI0810710A2 BR PI0810710 A2 BRPI0810710 A2 BR PI0810710A2 BR PI0810710 A BRPI0810710 A BR PI0810710A BR PI0810710 A2 BRPI0810710 A2 BR PI0810710A2
Authority
BR
Brazil
Prior art keywords
stabilizing
protein
Prior art date
Application number
BRPI0810710-6A2A
Other languages
English (en)
Inventor
Wolfgang Friess
Sylvia Kiese
Hanns-Christian Mahler
Astrid Pappenberger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0810710A2 publication Critical patent/BRPI0810710A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591Stabilisation, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0810710-6A2A 2007-05-02 2008-04-22 Método para estabilização de uma proteína. BRPI0810710A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07107353 2007-05-02
PCT/EP2008/054835 WO2008135380A1 (en) 2007-05-02 2008-04-22 Method for stabilizing a protein

Publications (1)

Publication Number Publication Date
BRPI0810710A2 true BRPI0810710A2 (pt) 2014-10-21

Family

ID=39674831

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810710-6A2A BRPI0810710A2 (pt) 2007-05-02 2008-04-22 Método para estabilização de uma proteína.

Country Status (11)

Country Link
US (1) US7879976B2 (pt)
EP (1) EP2144629A1 (pt)
JP (1) JP2010524479A (pt)
KR (1) KR101140483B1 (pt)
CN (1) CN101674847A (pt)
AU (1) AU2008248780B2 (pt)
BR (1) BRPI0810710A2 (pt)
CA (1) CA2685372A1 (pt)
IL (1) IL201391A0 (pt)
MX (1) MX2009011408A (pt)
WO (1) WO2008135380A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3225625A1 (en) 2002-09-11 2017-10-04 Chugai Seiyaku Kabushiki Kaisha Protein purification method
RU2476442C2 (ru) 2007-03-29 2013-02-27 Эббот Лэборетриз Кристаллические антитела против il-12 человека
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
GB0913773D0 (en) * 2009-08-07 2009-09-16 Isis Innovation Assay
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
US8821865B2 (en) 2010-11-11 2014-09-02 Abbvie Biotechnology Ltd. High concentration anti-TNFα antibody liquid formulations
US8883979B2 (en) 2012-08-31 2014-11-11 Bayer Healthcare Llc Anti-prolactin receptor antibody formulations
PE20150964A1 (es) 2012-09-07 2015-07-25 Coherus Biosciences Inc Formulaciones acuosas estables de adalimumab
KR20160037173A (ko) * 2013-08-02 2016-04-05 에프. 호프만-라 로슈 아게 치료학적 융합 단백질
DK3303396T5 (da) 2015-05-29 2024-10-07 Bristol Myers Squibb Co Antistoffer mod ox40 og anvendelser deraf
HUE057952T2 (hu) 2015-06-24 2022-06-28 Hoffmann La Roche Anti-transzferrin receptor antitestek testreszabott affinitással
TWI873952B (zh) 2015-10-02 2025-02-21 瑞士商赫孚孟拉羅股份公司 雙特異性抗‐人類cd20/人類轉鐵蛋白受體抗體及使用方法
AR106189A1 (es) 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
US11071782B2 (en) 2016-04-20 2021-07-27 Coherus Biosciences, Inc. Method of filling a container with no headspace
EP3448874A4 (en) * 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
KR20210062638A (ko) 2018-09-20 2021-05-31 레보 테라퓨틱스 인코포레이티드 카르베토신의 안정한 비강내 제형
AU2019345313A1 (en) 2018-09-20 2021-03-18 Levo Therapeutics, Inc. Carbetocin drug product and process for preparing same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666829A (en) 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
US6001643A (en) * 1997-08-04 1999-12-14 C-Med Inc. Controlled hydrodynamic cell culture environment for three dimensional tissue growth
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
AR038568A1 (es) 2002-02-20 2005-01-19 Hoffmann La Roche Anticuerpos anti-a beta y su uso
EP1541165A4 (en) * 2002-08-27 2009-06-24 Chugai Pharmaceutical Co Ltd METHOD FOR STABILIZING PROTEIN PREPARATION
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
RU2364609C2 (ru) * 2003-05-23 2009-08-20 Ново Нордиск Хелт Кэр Аг Стабилизация белка в растворе
AR046071A1 (es) 2003-07-10 2005-11-23 Hoffmann La Roche Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
RU2390353C2 (ru) * 2004-02-12 2010-05-27 Мерк Патент Гмбх Высококонцентрированные жидкие композиции анти-egfr антител
AU2005249360B2 (en) * 2004-04-12 2011-07-21 Medimmune, Llc Anti-IL-9 antibody formulations and uses thereof

Also Published As

Publication number Publication date
JP2010524479A (ja) 2010-07-22
KR101140483B1 (ko) 2012-07-11
CN101674847A (zh) 2010-03-17
IL201391A0 (en) 2010-05-31
CA2685372A1 (en) 2008-11-13
AU2008248780B2 (en) 2013-01-31
US7879976B2 (en) 2011-02-01
MX2009011408A (es) 2009-11-05
KR20090130867A (ko) 2009-12-24
EP2144629A1 (en) 2010-01-20
AU2008248780A1 (en) 2008-11-13
US20080275220A1 (en) 2008-11-06
WO2008135380A1 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
BRPI0810710A2 (pt) Método para estabilização de uma proteína.
BRPI0819127A2 (pt) Método para cimentar.
BRPI0814466A2 (pt) Método.
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
BRPI0807756A2 (pt) Método para produzir um l-aminoácido.
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
FI20075800L (fi) Menetelmä LNG-käyttöisen vesialuksen käyttämiseksi
BRPI0812446A2 (pt) Métodos para aperfeiçoamento de propriedades de proteína múltiplas
DK3118220T3 (da) Protein
CR10705A (es) Anticuerpos para linfotoxina-alfa
PT2223114T (pt) Calibrante para imunoensaios
BRPI0812096A2 (pt) Máquina para pegar e armazenar preendedores de trilho de uma linha férrea, e método.
BRPI0813569A2 (pt) Método de inspeção.
BRPI0814971A2 (pt) Proteína
BRPI0813858A2 (pt) Método para produzir peptídeo
BRPI0812741A2 (pt) Método para separação de glóbulos
BRPI0817885A2 (pt) Método para recuperar compostos bioativos.
BRPI0917345A2 (pt) composição, e, método para produzir uma composição estabilizada.
BRPI0813366A2 (pt) Método para executar uma combustão.
PT2214358T (pt) Método para o mapeamento de túneis
BRPI0815130A2 (pt) composição, e, método para fabricar uma composição
NL1036308A1 (nl) Lithographic method.
FI20065363A0 (fi) Erotusmenetelmä

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]